Despite the fact that ACE inhibition can contribute to AKI in certain conditions, it remains controversial whether ACE inhibitor or ARB medications should be discontinued prior to coronary angiography to minimize post-procedure AKI. The gene discussed is ACE; the disease is acute kidney injury.